Related Experiment Video
Updated: Aug 29, 2026

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
Published on: November 2, 2014
[Diagnosis and treatment of recurrent epithelial ovarian carcinoma]
Xu-feng Wu1, Hui-zhen Chen, Ding-fen Han
1Department of Gynecologic Oncology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
Objective:
To investigate the diagnosis, treatment and prognosis of recurrent epithelial ovarian carcinoma.
Methods:
Fifty-two patients with recurrent epithelial ovarian carcinoma who were admitted in Zhongnan Hospital of Wuhan University between 1997 and 2002 were analyzed retrospectively, and their diagnostic methods and the survival rates were compared.
Results:
The positive diagnostic rate of pelvic examination, CA(125) and ultrasound examination was 73.1%, 84.6% and 53.8%, respectively to the recurrent epithelial ovarian carcinoma. The median survival time of group A (surgery + chemotherapy) and group B (chemotherapy) was 11 and 12 months, respectively.
Conclusions:
The diagnostic methods should include pelvic examination, CA(125) and ultrasound examination. We could not know the exact role of surgery to the management and prognosis of recurrent epithelial ovarian carcinoma. Chemotherapy may have an important role to the management and prognosis of recurrent epithelial ovarian carcinoma.
Related Concept Videos
Treatment Resistant Cancers
Treatment Resistent Cancers

